Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Vivaldi, C.
216  Ergebnisse:
Personensuche X
?
1

Management of portal hypertension in patients receiving ate..:

Tovoli, F. ; Franceschini, E. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S87 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Aetiology of hepatocellular carcinoma and response to immun..:

Tovoli, F. ; Chen, R. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S92-S93 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Efficacy and safety of atezolizumab/bevacizumab for hepatoc..:

Tovoli, F. ; Vivaldi, C. ; Federico, P....
Digestive and Liver Disease.  56 (2024)  - p. S85-S86 , 2024
Link: https://doi.org/10.1016/..
 
?
4

The impact of etiology on patterns of progression of advanc..:

Stefanini, B. ; Piscaglia, F. ; Dalbeni, A....
Digestive and Liver Disease.  56 (2024)  - p. S17 , 2024
Link: https://doi.org/10.1016/..
 
?
5

The synergic effect of metformin with atezolizumab/ bevaciz..:

Dalbeni, A. ; Vicardi, M. ; Natola, L.A....
Digestive and Liver Disease.  56 (2024)  - p. S89-S90 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Characteristics and outcomes of immunotherapy-related liver..:

Celsa, C. ; Cabibbo, G. ; Fulgenzi, C. AM...
Digestive and Liver Disease.  56 (2024)  - p. S76-S78 , 2024
Link: https://doi.org/10.1016/..
 
?
7

189P The synergic effect of metformin and atezolizumab/beva..:

Dalbeni, A. ; Auriemma, A. ; Stefanini, B....
Annals of Oncology.  35 (2024)  - p. S85 , 2024
Link: https://doi.org/10.1016/..
 
?
8

185P The combined role of patients (pts) gender and disease..:

Cesario, S. ; Genovesi, V. ; Rimini, M....
Annals of Oncology.  35 (2024)  - p. S83 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Sorafenib as a second-line treatment after failure of atezo..:

Tovoli, F. ; Boe, M. ; Vivaldi, C....
Digestive and Liver Disease.  56 (2024)  - p. S79 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Identification of factors associated with primary refractor..:

Manfredi, G.F. ; Fulgenzi, C.A.M. ; D'Alessio, A....
Digestive and Liver Disease.  56 (2024)  - p. S8-S9 , 2024
Link: https://doi.org/10.1016/..
 
?
11

381P Evaluation of the prognostic impact of circulating fre..:

Grelli, G. ; Crucitta, S. ; Genovesi, V....
Annals of Oncology.  35 (2024)  - p. S154 , 2024
Link: https://doi.org/10.1016/..
 
?
12

292P Extended molecular profiling (EMP) and access to targe..:

Genovesi, V. ; Rimini, M. ; Pressiani, T....
Annals of Oncology.  35 (2024)  - p. S123 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Incidence and risk factors of esophagogastric varices bleed..:

Iavarone, M. ; Alimenti, E. ; Tada, T....
Digestive and Liver Disease.  55 (2023)  - p. S67-S68 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Clinical impact of relative dose intensity of cabozantinib ..:

Tovoli, F. ; Dadduzio, V. ; De Lorenzo, S....
Digestive and Liver Disease.  55 (2023)  - p. S224-S225 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Early and midterm results of radiofrequency ablation (Rafae..:

Tolksdorf, S. ; Tübergen, D. ; Vivaldi, C....
Techniques in Coloproctology.  26 (2022)  6 - p. 479-487 , 2022
Link: https://doi.org/10.1007/..
 
1-15